Lu Qiang
Papers
1
Total Citations
22
H-Index
1
About
Dr. Lu Qiang is a leading figure in urologic oncology, with a primary research focus on the comparative effectiveness of minimally invasive treatments for renal cell carcinoma. His most impactful work provides a rigorous, evidence-based evaluation of thermal ablation versus surgical resection for small renal masses. In his landmark 2014 systematic review and meta-analysis, Dr. Qiang synthesized data from multiple studies to compare radiofrequency ablation (RFA) with partial nephrectomy for clinical stage 1 tumors. This critical analysis, which has garnered 22 citations, helped clarify the evolving treatment paradigm for small renal masses by quantifying the trade-offs between oncologic efficacy and nephron-sparing benefits. His research directly addresses the rising incidence of incidentally detected kidney cancers, offering clinicians and patients clearer guidance on balancing cancer control with renal function preservation. Dr. Qiang’s contributions are instrumental in shaping modern, less invasive strategies for kidney cancer management, making him a key voice in the ongoing shift toward tailored, organ-sparing therapies.
Research Focus
Key Achievements
Top Papers
- 1